ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 119 filers reported holding ANAPTYSBIO INC in Q4 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,521 | +566.9% | 140,499 | +469.5% | 0.02% | +700.0% |
| Q4 2023 | $528 | -27.5% | 24,672 | -39.1% | 0.00% | -57.1% |
| Q3 2023 | $728 | -59.6% | 40,539 | -54.2% | 0.01% | -53.3% |
| Q2 2023 | $1,802 | -38.2% | 88,585 | -33.9% | 0.02% | -37.5% |
| Q1 2023 | $2,917 | -1.2% | 134,042 | +40.7% | 0.02% | -44.2% |
| Q4 2022 | $2,952 | -99.7% | 95,258 | +162.8% | 0.04% | +258.3% |
| Q3 2022 | $925,000 | -57.7% | 36,241 | -66.3% | 0.01% | -55.6% |
| Q2 2022 | $2,185,000 | +14.0% | 107,624 | +39.0% | 0.03% | +12.5% |
| Q1 2022 | $1,916,000 | +830.1% | 77,446 | +919.2% | 0.02% | +700.0% |
| Q3 2021 | $206,000 | -76.4% | 7,599 | -77.4% | 0.00% | -70.0% |
| Q2 2021 | $873,000 | +323.8% | 33,679 | +141.4% | 0.01% | +150.0% |
| Q3 2020 | $206,000 | -68.1% | 13,949 | -51.7% | 0.00% | -76.5% |
| Q2 2020 | $646,000 | – | 28,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $53,362,000 | 8.10% |
| EcoR1 Capital, LLC | 7,521,024 | $152,677,000 | 5.27% |
| GREAT POINT PARTNERS LLC | 453,118 | $9,198,000 | 2.21% |
| Soleus Capital Management, L.P. | 643,575 | $13,065,000 | 2.04% |
| Frazier Life Sciences Management, L.P. | 899,700 | $18,264,000 | 1.72% |
| Boxer Capital, LLC | 1,300,000 | $26,390,000 | 1.67% |
| Deep Track Capital, LP | 672,569 | $13,653,000 | 0.90% |
| Palo Alto Investors LP | 431,024 | $8,750,000 | 0.76% |
| TCG Crossover Management, LLC | 58,515 | $1,188,000 | 0.50% |
| HighVista Strategies LLC | 33,103 | $672,000 | 0.41% |